ArticleJournal of cancer research and clinical oncology2023

The safety and feasibility of preoperative induction therapy of Savolitinib in non-small cell lung cancer patients with MET exon 14 skipping mutation.

Han-Yu Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.